We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA warned Abraxis Bioscience for distributing pharmaceuticals that could have been contaminated during manufacture and for marketing drugs without approved new drug applications.
As Capitol Hill contemplates proposed legislation to establish approval mechanisms and analytical processes at the FDA to facilitate biogeneric entry, biotech firms are urging federal lawmakers to reject assertions in two highly publicized studies that claim follow-on biologics would save billions in healthcare costs.
Children under 5 immunized with FluMist had 55 percent fewer cases of influenza compared with children who received the flu shot, according to a recent study.
Americans who attempted to purchase certain drugs over the internet instead received products containing haloperidol, a strong anti-psychotic drug, the FDA said.
The Michigan House of Representatives voted to repeal a state law that prevents residents from suing drug companies -- the only law of its kind in the country.
Two companies have announced they are taking steps to provide easier access to needed medications in developing countries, while an advocacy group claims a third company is preventing access to HIV medication through an overload of patents.
Starpharma signed a funding agreement this week with several federal agencies for further study of VivaGel, an HIV and genital herpes prevention drug, in sexually active women.